
![]()
- Molecular FormulaC8H20N2
- Average mass144.258 Da

References
- ^ “Octamoxin – Compound Summary”. USA: National Center for Biotechnology Information. 26 March 2005. Identification and Related Records. Retrieved 31 May 2012.
- ^ “Dictionary of pharmacological agents – Google Books”.
- ^ “13-06781. Octamoxin [Archived]: The Merck Index”.
- ^ Levy J, Michel-Ber E (1966). “[Relations between the antidepressive effects of octamoxine revealed by 3 pharmacological tests and inhibition of cerebral monoamine oxidase in mice]”. Thérapie (in French). 21 (4): 929–45. PMID 5925088.
- ^ Gayral L, Stern H, Puyuelo R (1966). “[Indications and results of the treatment of mental depression by octamoxine (ximaol)]”. Thérapie (in French). 21 (5): 1183–90. PMID 5976767.
| Names | |
|---|---|
| Preferred IUPAC name
1-Methylheptylhydrazine[citation needed]
|
|
| Systematic IUPAC name
Octan-2-ylhydrazine[1]
|
|
| Identifiers | |
|
3D model (JSmol)
|
|
| ChemSpider | |
|
PubChem CID
|
|
| UNII | |
| Properties | |
| C8H20N2 | |
| Molar mass | 144.262 g·mol−1 |
| Density | 0.831 g/mL |
| Boiling point | 228 °C (442 °F; 501 K) |
| Pharmacology | |
| Oral | |
| Related compounds | |
|
Related compounds
|
Tuaminoheptane |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO
.....
